Organigram Holdings Stock Today
| OGI Stock | CAD 2.14 0.01 0.47% |
Performance0 of 100
| Odds Of DistressLess than 22
|
OrganiGram Holdings is selling at 2.14 as of the 29th of November 2024; that is 0.47 percent increase since the beginning of the trading day. The stock's open price was 2.13. OrganiGram Holdings has about a 22 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for OrganiGram Holdings are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of August 2024 and ending today, the 29th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
OrganiGram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. OrganiGram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada. ORGANIGRAM HOLDINGS operates under Drug ManufacturersSpecialty Generic classification in Canada and is traded on Toronto Stock Exchange. The company has 108.57 M outstanding shares of which 519.71 K shares are now shorted by private and institutional investors with about 2.92 days to cover all short positions. More on OrganiGram Holdings
Moving against OrganiGram Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
OrganiGram Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. OrganiGram Holdings' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding OrganiGram Holdings or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Gregory Engel | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | ||||
OrganiGram Holdings' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to OrganiGram Holdings' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsOrganiGram Holdings can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand OrganiGram Holdings' financial leverage. It provides some insight into what part of OrganiGram Holdings' total assets is financed by creditors.
| |||||
OrganiGram Holdings (OGI) is traded on Toronto Exchange in Canada and employs 914 people. OrganiGram Holdings is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 231.26 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate OrganiGram Holdings's market, we take the total number of its shares issued and multiply it by OrganiGram Holdings's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. OrganiGram Holdings operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 108.57 M outstanding shares of which 519.71 K shares are now shorted by private and institutional investors with about 2.92 days to cover all short positions.
OrganiGram Holdings has accumulated about 44.78 M in cash with (35.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.23.
Check OrganiGram Holdings Probability Of Bankruptcy
Ownership AllocationOrganiGram Holdings owns a total of 108.57 Million outstanding shares. OrganiGram Holdings has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check OrganiGram Ownership Details
OrganiGram Holdings Risk Profiles
Although OrganiGram Holdings' alpha and beta are two of the key measurements used to evaluate OrganiGram Holdings' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.01 | |||
| Standard Deviation | 2.6 | |||
| Variance | 6.74 | |||
| Risk Adjusted Performance | (0.05) |
OrganiGram Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in OrganiGram Holdings without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
OrganiGram Holdings Corporate Management
Elected by the shareholders, the OrganiGram Holdings' board of directors comprises two types of representatives: OrganiGram Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of OrganiGram. The board's role is to monitor OrganiGram Holdings' management team and ensure that shareholders' interests are well served. OrganiGram Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, OrganiGram Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA | Chief Officer | Profile | |
| Beena Goldenberg | CEO Director | Profile | |
| Katrina McFadden | Chief Officer | Profile | |
| Raymond Gracewood | Senior Vice President of Marketing and Communications | Profile | |
| Megan McCrae | Senior Communications | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OrganiGram Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in OrganiGram Stock, please use our How to Invest in OrganiGram Holdings guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.